EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2
Open Access
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 57 (5) , 722-725
Abstract
No abstract availableKeywords
Funding Information
- Meridigen Biotech Co. Ltd., Taipei, Taiwan (2017-RD-VIT-003)
This publication has 18 references indexed in Scilit:
- Paracrine Mechanisms of Mesenchymal Stem Cells in Tissue Repair2016
- EphA2 is a biomarker of hMSCs derived from human placenta and umbilical cordTaiwanese Journal of Obstetrics and Gynecology, 2015
- Inhibitory effects of prostaglandin E2on collagen synthesis and cell proliferation in human stellate cells from pancreatic head adenocarcinomaBMC Cancer, 2014
- The wound healing, chronic fibrosis, and cancer progression triadPhysiological Genomics, 2014
- Prostaglandin E2 Stimulates the Production of Vascular Endothelial Growth Factor through the E-Prostanoid–2 Receptor in Cultured Human Lung FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Regulation of Immune Responses by Prostaglandin E2The Journal of Immunology, 2012
- Prostaglandin E2 and the Pathogenesis of Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Prostaglandin E 2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1American Journal of Respiratory Cell and Molecular Biology, 2008
- Tissue-specific Mechanisms for CCN2/CTGF Persistence in Fibrotic GingivaJournal of Biological Chemistry, 2007
- Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cellsBlood, 2003